Healthcare

This research service encompasses microbiome technology trends and emerging innovations across: Disease Management This research segment explores the emerging role of microbiome-based therapeutics across a wide range of diseases, especially in the context of gastro-intestinal health, while providing strategic insights across the highly dynamic com...

The impressive advances in life sciences research and development (R&D) befallen in the past two-three years are playing a leading role in the transformation of the healthcare industry. A myriad of new developments in the fields of gene and cell therapies, empowered with nanotechnology advances, omics technologies and novel smart molecules approach...

The drug approvals of Yescarta (axicabtagene ciloleucel), Luxturna (Voretigene neparvovec) and Kymriah (Tisagenlecleucel) have turned a leaf in the pharmaceutical chapter of gene therapy development. Currently, genetic disorders do not have satisfactory treatment outcomes. This is in part due to the inability of small molecule drugs and enzyme repl...

Recent advancement in the development of novel platforms of smart targeting small molecules, gene therapy, stem cell therapy, gene modification, and gene rectification technologies pose new prospects for therapies and cures for rare and genetic diseases. More than 80% of rare diseases are genetic in origin, so that gene and cell therapies are being...

Healthcare-associated infection (HAI) continues to be a significant global concern, hence there is growing research for developing new antimicrobial platforms that can significantly decrease the risk of microbial infections. While metallic ions continue to be one of the most potent antimicrobial technology platform, several new innovations across a...

With the healthcare industry moving toward patient convenience and comfort, pharmaceutical and medical device companies are continuously researching for the most effective, side effect free, convenient route of drug delivery. Transdermal drug delivery is a painless method of delivering drug formulation. Transdermal route of drug administration has ...

TechVisions latest research service profiles innovations in sensing technologies and their impact on clinical diagnosis. The emergence of point of care (PoC) testing has necessitated compact, more portable testing kits, to replace laboratory testing. In the light of global epidemic outbreaks, there is also a greater need for high throughput testing...

This strategic research service, Health & Wellness Top 10 Technologies, depicts the current landscape and the new trends in a series of developments associated with innovations in Precision Oncology, Biobetters,Human Microbiomics, Immune Engineering, Cancer/Tumor Profiling, Cellular Therapeutics, Tissue Engineering, Molecular Diagnostics, Gene Edit...

This research service covers key technological trends and developments across global analgesic products and technologies that are likely to have a high impact in the near future. Based on the observation of the global analgesic industry, advances and technological trends across existing and emerging technologies have been detailed. While providing ...